Compare Kinder Morgan Inc (KMI) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs Zoetis Inc — how do they compare? Kinder Morgan Inc trades at $31.7 (market cap $70.10B), while Zoetis Inc trades at $73.68 (market cap $31.14B). The key difference: Kinder Morgan Inc is far larger — about 2.3× Zoetis Inc's market cap, and Kinder Morgan Inc pays the higher dividend (3.75%). Which is the better fit depends on your goals.
| KMI | ZTS | |
|---|---|---|
Market Cap | $70.10B | $31.14B |
Sector | Energy | Health |
52-Week High | $34.31 | $156.76 |
52-Week Low | $25.84 | $71.91 |
Enterprise Value | $102.15B | $38.70B |
Dividend Yield | 3.75% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KMI trades at $31.70, up 0.99% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates, and raised full-year guidance. Recent news highlights a $5 billion joint venture for the Western Gateway Pipeline, signaling growth in natural gas infrastructure. Fundamentals show solid revenue growth, with 2025 revenue at $16.94 billion and net income margin improving to 19.31%.
The outlook is positive due to contracted cash flows and a robust project pipeline, but risks include high debt levels and exposure to energy market volatility. Analyst sentiment is mixed, with a near-even split between buy and hold ratings. The stock offers a dividend yield supported by stable cash generation, though valuation multiples like a P/E of 20.31 may limit near-term upside.
Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.
The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
